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1655procedural factors such as jailed wire or pre-dilation in the SB
are not known. Moreover, impact of sizable SB occlusion on
clinical outcomes has not been well studied. Therefore,
we investigated predictors and outcomes of SB occlusion after
MV stenting in bifurcation lesions, using a large bifurcation
registry.MACE = major adverse
cardiac event(s)
MI = myocardial infarction
MV = main vessel
PCI = percutaneous coronary
intervention
SB = side branch
TIMI = Thrombolysis In
Myocardial Infarction
TLR = target lesion
revascularizationMethods
A detailed description of the study methods is presented in
the Online Appendix.
Study population. The COBIS (COronary BIfurcation
Stenting) II registry is a retrospective multicenter registry of
patients with coronary bifurcation lesions undergoing PCI
with drug-eluting stents (DES). From January 2003 through
December 2009, 2,897 consecutive patients were enrolled
from 18 major coronary intervention centers in Korea. In-
clusion criteria were: 1) coronary bifurcation lesions treated
with DES only; and 2) MV diameter of 2.5 mm and SB
diameter of 2.3 mm conﬁrmed by core laboratory quan-
titative coronary analysis. Exclusion criteria were: 1) cardio-
genic shock or experience of cardiopulmonary resuscitation;
and 2) protected left main disease. The local institutional
review board at each hospital approved this study.
To investigate predictors of SB occlusion immediately after
MV stenting, we excluded patients undergoing elective SB
stenting beforeMVstenting and selected patients treatedwith
the 1-stent technique or MV stenting ﬁrst strategy (n ¼
2,365). Patients with restenotic bifurcation lesions (n ¼ 107)
or bifurcation lesions in which the SB had decreased pre-
procedural Thrombolysis In Myocardial Infarction (TIMI)Figure 1
Schematic Diagram of Quantitative Coronary
Angiographic Analysis
Bifurcation lesions were analyzed as follows: (1) main vessel (MV) proximal
reference diameter (RD); (2) MV distal RD; (3) side branch (SB) distal RD; (4) MV
proximal (proximal to SB take off) minimum luminal diameter (MLD); (5) MV distal
(<5 mm distal to takeoff) MLD; (6) SB ostial MLD; (7) MV lesion length; and (8) SB
lesion length.ﬂow (n ¼ 31) were excluded.
Finally, 2,227 patients who met
the selection criteria were in-
cluded in the analysis.
Data collection and analysis.
Data were collected using a Web-
based reporting system. Coronary
angiograms were reviewed and
analyzed quantitatively by an inde-
pendent core laboratory at Sam-
sung Medical Center (detailed in
the Online Appendix). Bifurca-
tion lesions were divided into 3
segments for quantitative coronary
angiographic analysis: proximal
MV, distal MV, and SB ostium
(Fig. 1).
Study outcomes and deﬁnitions. SB occlusion was deﬁned
as TIMI ﬂow grade <3 immediately after MV stenting. We
also performed further analysis using the deﬁnition of SB
occlusion as TIMI ﬂow grade 0 or 1. Clinical events were
deﬁned based on recommendations from the Academic
Research Consortium (detailed in the Online Appendix) (6).
Major adverse cardiac events (MACE) were deﬁned as
a composite of cardiac death, myocardial infarction (MI), or
target lesion revascularization (TLR). All events were re-
ported by the principal investigator of each hospital and
conﬁrmed by source documentation.
Statistical analysis. Multivariate logistic regression analysis
was performed to identify independent predictors of SB
occlusion (detailed in the Online Appendix). The Cox
proportional hazards method was used to test whether SB
occlusion is an independent predictor of clinical outcomes
(detailed in the Online Appendix). All p values were
2-tailed, and a p value of <0.05 was considered statistically
signiﬁcant.Results
Patient characteristics. Of 2,227 bifurcation lesions
treated with the 1-stent technique or MV stenting ﬁrst
strategy, SB occlusion occurred in 187 (8.4%) patients.
Baseline characteristics of patients are shown in Table 1.
Bifurcation location and a prevalence of true bifurcation
were signiﬁcantly different between the 2 groups (Table 2).
SB pre-dilation was performed more frequently, but intra-
vascular ultrasound (IVUS) was used less frequently in
patients with SB occlusion than in those without SB oc-
clusion. Quantitative coronary angiographic data are pre-
sented in Table 3. The angle between the MV and SB was
not signiﬁcantly different between the 2 groups.
Multivariate analysis. Independent predictors of SB oc-
clusion are presented in Table 4. Neither pre-procedural
percent diameter stenosis of the distal MV 50% nor
SB pre-dilation was predictive of SB occlusion. The area
under the receiver-operating characteristic (ROC) curve was
Table 1 Baseline Clinical Characteristics
Characteristic
SB Occlusion
(n ¼ 187)
No SB Occlusion
(n ¼ 2,040) p Value
Age, years (range) 62.0 (54.0–70.0) 63.0 (55–69) 0.84
Male 133 (71.1) 1,485 (83.1) 0.62
Hypertension 99 (52.9) 1,203 (59.0) 0.11
Diabetes mellitus 42 (22.5) 591 (29.0) 0.06
Dyslipidemia 69 (36.9) 640 (31.4) 0.12
Current smoker 57 (30.5) 527 (25.8) 0.17
Previous myocardial
infarction
12 (6.4) 96 (4.7) 0.30
Previous
revascularization
24 (12.8) 228 (11.2) 0.49
Clinical presentation 0.001
Stable coronary
artery disease
49 (26.2) 788 (38.6)
Acute coronary
syndromes
138 (73.8) 1,252 (61.4)
LVEF, % (range)* 56.0 (47.0–63.0) 60.0 (54.0–65.7) <0.001
Values are median (interquartile range) or n (%). *Available in 157 patients (84.0%) with
side branch (SB) occlusion and 1,668 patients (81.8%) without SB occlusion.
LVEF ¼ left ventricular ejection fraction; SB ¼ side branch.
Table 2 Lesion and Procedural Characteristics
Characteristic
SB Occlusion
(n ¼ 187)
No SB Occlusion
(n ¼ 2,040) p Value
Bifurcation location <0.001
Left main
bifurcation
14 (7.5) 556 (27.3)
LAD/diagonal 124 (66.3) 1,124 (55.1)
LCX/OM 32 (17.1) 272 (13.3)
RCA bifurcation 17 (9.1) 88 (4.3)
Medina classiﬁcation <0.001
1.1.1 97 (51.9) 567 (27.8)
1.0.1 21 (11.2) 136 (6.7)
0.1.1 21 (11.2) 198 (9.7)
1.0.0 19 (10.2) 297 (14.6)
1.1.0 25 (13.4) 355 (17.4)
0.1.0 4 (2.1) 462 (22.6)
0.0.1 0 (0.0) 25 (1.2)
True bifurcation 139 (74.3) 901 (44.2) <0.001
Type of stent used 0.83
Sirolimus-eluting
stent
82 (43.9) 966 (47.4)
Paclitaxel-eluting
stent
50 (26.7) 545 (26.7)
Zotarolimus-
eluting stent
23 (12.3) 234 (11.5)
Everolimus-eluting
stent
26 (13.9) 246 (12.1)
Other drug-eluting
stents
6 (3.2) 49 (2.4)
Jailed wire in the SB 123 (65.8) 1,237 (60.6) 0.17
SB pre-dilation
before MV
stenting
61 (32.6) 437 (21.4) <0.001
Guidance of
intravascular
ultrasound
52 (27.8) 772 (37.8) 0.007
MV stent diameter,
mm (range)
3.0 (3.0–3.5) 3.0 (3.0–3.5) 0.04
MV stent length, mm
(range)
24.0 (20.0–30.0) 24.0 (18.0–30.0) 0.21
MV stent maximal
pressure, atm
(range)
12.0 (10.0–14.0) 14.0 (10.0–16.0) <0.001
MV stent/artery ratio
(range)
1.2 (1.1–1.3) 1.2 (1.1–1.3) 0.63
Values are median (interquartile range) or n (%).
LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex artery; MV ¼ main vessel;
OM ¼ obtus marginal; RCA ¼ right coronary artery.
Hahn et al. JACC Vol. 62, No. 18, 2013
Predictors and Outcomes of Side Branch Occlusion October 29, 2013:1654–9
16560.75 (95% CI: 0.72 to 0.78) and the Brier score was 0.073.
The degree of optimism was 0.024 for the area under the
ROC curve, which was acceptable.
Fate of occluded SB after MV stenting. SB ﬂow was
restored spontaneously in 26 lesions (13.9%) and by SB
intervention in 103 (55.1%) lesions but not in 58 (31.0%) of
187 occluded SB. For SB interventions, balloon angioplasty
was performed in 88 lesions, and stenting was performed in
the SB in 29 lesions. SB was permanently occluded despite
ballooning in 11 patients and stenting in 3 patients. Patients
with recovery of the occluded SB had jailed wire in the SB
more frequently than those without recovery of the oc-
cluded SB (74.8% vs. 57.8%, p ¼ 0.02). No other clinical,
angiographic, or procedural variables were associated with
ﬂow recovery (Online Tables 1 to 3).
Clinical outcomes. During follow-up (median: 36 months;
interquartile range: 25 to 51 months), SB occlusion was
signiﬁcantly associated with clinical outcomes (Table 5,
Fig. 2). In an explanatory 1-month landmark analysis, stent
thrombosis occurred more frequently in patients with SB
occlusion than in those without SB occlusion, whereas there
were no signiﬁcant differences in other outcomes between
the 2 groups after 1 month (Online Fig. 1). Clinical
outcomes were more favorable with recovered SB than with
persistently occluded SB (see Online Results section and
Online Table 4). Among 129 patients with recovered SB,
the rate of MACE was signiﬁcantly higher in the 2-stent
group than in the 1-stent group (23.1% vs. 7.8%, p ¼
0.03). Stent thrombosis occurred in 2 patients (7.7%) of the
2-stent group and in 2 patients (1.9%) of the 1-stent group
(p ¼ 0.18).
Additional analysis using deﬁnition of SB occlusion as
TIMI ﬂow grade 0 or 1. SB occlusion after MV stenting
occurred in 108 (4.8%) of 2,227 bifurcation lesions. Similarresults were found even if SB occlusion was deﬁned as TIMI
ﬂow grades 0 to 1 (see Online Results section and Online
Table 5).Discussion
Currently, most bifurcation lesions are treated with a provi-
sional strategy (7). However, SB occlusion after MV stent-
ing is one of the most serious complications during the
procedure and may be the major reason why operators prefer
the systematic 2-stent technique in the complex bifurcation
lesions. Predicting the risk of SB occlusion could improve
Table 3 Quantitative Coronary Angiographic Analysis
Timing
SB Occlusion
(n ¼ 187)
No SB Occlusion
(n ¼ 2,040) p Value
Before procedure
MV proximal RD, mm* 3.2 (2.9–3.6) 3.4 (3.0–3.8) 0.001
MV distal RD, mm 2.7 (2.4–2.9) 2.7 (2.4–3.0) 0.14
SB distal RD, mm 2.3 (2.3–2.4) 2.4 (2.3–2.7) <0.001
MV proximal MLD, mm 1.2 (0.7–1.6) 1.6 (1.0–2.4) <0.001
MV distal MLD, mm 1.2 (0.9–1.7) 1.3 (0.9–1.8) 0.03
SB ostial MLD, mm 1.0 (0.7–1.5) 1.6 (1.1–2.1) <0.001
MV proximal diameter stenosis, %* 63.3 (53.8–79.0) 54.0 (29.2–69.7) <0.001
MV distal diameter stenosis, % 57.4 (36.9–68.0) 53.1 (34.1–66.2) 0.047
SB diameter stenosis, % 56.5 (39.3–71.6) 36.3 (18.2–55.3) <0.001
MV lesion length, mm 19.5 (12.2–26.9) 15.6 (10.0–24.2) 0.001
SB lesion length, mm 4.3 (0.6–9.7) 0.0 (0.0–5.5) <0.001
Bifurcation angle,  57.7 (45.3–72.6) 59.4 (46.0–77.0) 0.19
Immediately after MV stenting
MV proximal MLD, mm 2.8 (2.5–3.1) 3.0 (2.7–3.4) <0.001
MV distal MLD, mm 2.7 (2.4–3.0) 2.8 (2.5–3.1) 0.001
MV proximal diameter stenosis, %* 12.1 (4.3–25.0) 11.0 (3.1–20.0) 0.01
MV distal diameter stenosis, % 1.7 (5.9–12.0) 0.0 (10.1–8.4) 0.006
Values are median (interquartile range). *Available in 181 patients with SB occlusion and 1,935 patients without SB occlusion.
MLD ¼ minimum luminal diameter; RD ¼ reference diameter.
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this issue to date. Although several previous studies re-
ported that SB ostial disease was an independent predictor
of SB occlusion, those studies had several major limitations
(3–5,8). The size of the SB was small (<1.5 mm), and left
main bifurcation lesions were not included. Sample sizes
were too small to draw deﬁnite conclusions. Moreover,
bare-metal stents were used in earlier studies, which do not
reﬂect contemporary real-world practice. Therefore, we
sought to identify predictors of SB occlusion using data
from the COBIS II registry.
SB ostial stenosis was one of the independent predictors of
SB occlusion, concordant with the results of previous studies
(3–5). In addition, SB lesion length was also signiﬁcantly
associated with SB occlusion. An IVUS study reported that SB
occlusion occurred more frequently with diffuse atherosclerotic
plaque than with focal stenosis in the SB ostium (9). Inter-
estingly, the proximal MV stenosis, but not the distal MV
stenosis, was independently predictive of SB occlusion. Plaque
shift was signiﬁcantly correlated with plaque volume decrease
in the proximal MV segment but not with plaque volume
decrease in the distal MV segment by volumetric IVUSTable 4 Independent Predictors of SB Occlusion
Variable Odds Ratio (95% CI) (range) p Value
Pre-procedural %DS of the SB 50% 2.34 (1.59–3.43) <0.001
Pre-procedural %DS of the
proximal MV 50%
2.34 (1.57–3.50) 0.03
SB lesion length 1.03 (1.003–1.06) <0.001
Acute coronary syndrome 1.53 (1.06–2.19) 0.02
Left main lesions
(vs. non-left main lesions)
0.34 (0.16–0.72) 0.005
CI ¼ conﬁdence interval; %DS ¼ percent diameter stenosis.analysis (10). These data suggest that plaque in the proximal
MV segment is more important for SB occlusion than plaque
in the distal MV segment. Acute coronary syndromes were
signiﬁcantly associated with SB occlusion after MV stenting.
IVUS imaging in patients with acute coronary syndromes
demonstrated that culprit lesions were characterized by
thrombus and greater plaque burden, which supports our
ﬁndings (11). Unexpectedly, SB occlusion occurred less
frequently in left main lesions than in non-left main lesions.
Operators might adopt an elective 2-stent strategy more
aggressively in left main lesions to avoid occlusion of the left
circumﬂex artery. The angle between the MV and SB was not
an independent predictor of SB occlusion. Although bifurca-
tion angle has been regarded as one of the important factors for
bifurcation PCI, there is a paucity of data regarding its impact
on SB occlusion or clinical outcomes. Recently, our group
reported that bifurcation angle did not inﬂuence ﬁnal TIMI
ﬂow grade in the SB and long-term clinical outcomes, which is
concordant to the results of the present study (12). Among
procedural factors, pre-dilation or wiring in the SB did not
prevent SB occlusion. However, jailed wire in the SB was
associated with recovery of the occluded SB. Therefore, we
encourage routine wiring in the SB when bifurcation lesions
are treated with the provisional approach.
Previous studies reported that SB occlusion was not
associated with adverse outcomes (3–5). However, in our
study, patients with SB occlusion had worse clinical out-
comes than patients without SB occlusion. This discrepancy
can be attributable to larger SB and inclusion of left main
bifurcation lesions in our study. Whereas worse outcome
related to SB occlusion was caused mainly by cardiac death
occurring during the very early period, landmark analysis
showed that the risk of stent thrombosis was consistently
Table 5 Clinical Outcomes at 12-Month Follow-Up
Outcome
SB Occlusion
(n ¼ 187)
No SB Occlusion
(n ¼ 2,040)
Unadjusted HR
(95% CI) p Value
Adjusted HR*
(95% CI) p Value
Death 10 (5.3) 74 (3.6) 1.55 (0.80–2.99) 0.20 1.50 (0.76–2.97) 0.24
Cardiac death 7 (3.7) 20 (1.0) 3.95 (1.67–9.35) 0.002 4.19 (1.66–10.59) 0.002
MI 4 (2.1) 32 (1.6) 1.44 (0.59–4.07) 0.49 1.50 (0.51–4.41) 0.46
Cardiac death or MI 10 (5.3) 50 (2.5) 2.29 (1.16–4.52) 0.02 2.34 (1.15–4.77) 0.02
Stent thrombosisy 6 (3.2) 9 (0.4) 7.68 (2.73–21.59) <0.001 6.19 (2.00–19.13) 0.002
TLR 14 (7.5) 129 (6.3) 1.26 (0.73–2.19) 0.41 1.31 (0.74–2.30) 0.36
MACE 23 (12.3) 164 (8.0) 1.63 (1.06–2.53) 0.03 1.64 (1.05–2.58) 0.03
Values are n (%). *Adjusted covariates included diabetes, acute coronary syndromes, true bifurcation, left main lesion, use of intravascular ultrasound, SB pre-dilation, MV stent diameter, and MV stent
maximal pressure. yDeﬁnite or probable stent thrombosis.
CI ¼ conﬁdence interval; HR ¼ hazard ratio; MACE ¼ major adverse cardiac events; MI ¼ myocardial infarction; TLR ¼ target lesion revascularization.
Hahn et al. JACC Vol. 62, No. 18, 2013
Predictors and Outcomes of Side Branch Occlusion October 29, 2013:1654–9
1658higher in patients with SB occlusion than in those with-
out SB occlusion. Although we cannot provide the exact
mechanism, SB occlusion may impact short-term as well as
long-term clinical outcomes.
Study limitations. Our large sample size made multivariate
analyses for SB occlusion and clinical outcomes possible.
However, the discriminative ability of our multivariateFigure 2 Kaplan-Meier Curves for Clinical Outcomes
(A) Kaplan-Meier curves for cardiac death (c-death) or myocardial infarction (MI) in patien
stenting. (B) Kaplan-Meier curves for target lesion revascularization (TLR). (C) Kaplan-Me
deﬁnite or probable stent thrombosis (ST).model evaluated by ROC curves was reasonable but not
excellent. According to our model, unpredictable SB oc-
clusion after MV stenting can occur in substantial numbers
of patients. The overﬁtting problems of Cox hazard model
for clinical outcomes are another limitation of our analysis.
Because it is not practical to make a separate multivariate
survival model for each outcome, we constructed a singlets with SB occlusion after MV stenting versus those without SB occlusion after MV
ier curves for major adverse cardiac events (MACE). (D) Kaplan-Meier curves for
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avoided regarding the outcomes with few events such as
stent thrombosis.
The strength of our study over previous studies is that we
included only bifurcation lesions with SB 2.3 mm and left
main bifurcation lesions. Therefore, SBs that we studied
were more clinically important than SBs examined in pre-
vious studies. However, there are several limitations to our
study. First, although procedural factors were not associated
with SB occlusion in our study, we cannot completely ex-
clude the protective effects of pre-dilation or wiring in the
SB which might be performed in SBs with greater jeopardy
of occlusion. Second, data on clinical outcomes at 3 years
were available in only half of all patients. However, the
follow-up rate was similar in both groups.
Conclusions
Using data from a large bifurcation registry, pre-procedural
stenosis and lesion length of the SB, proximal MV stenosis,
and clinical presentation were found to be predictive of
SB occlusion after MV stenting. Jailed wire in the SB might
be helpful for recovery of the occluded SBs. Occlusion of
sizable SB was associated with adverse outcomes.
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